Seoul Pharma Co. Ltd (018680) — Cash Flow Reinvestment Rate
Seoul Pharma Co. Ltd (018680) has a Cash Flow Reinvestment Rate of 0.52x as of June 2025, reinvesting ₩1.07 Billion (capex ₩89.75 Million plus investments ₩979.26 Million) from operating cash flow of ₩2.07 Billion. Explore 018680 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seoul Pharma Co. Ltd Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for Seoul Pharma Co. Ltd across 8 annual periods. Also explore 018680 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year capital reinvestment analysis for Seoul Pharma Co. Ltd. For live market cap and broader valuation context, see how much is Seoul Pharma Co. Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.47x | ₩7.76 Billion | ₩5.26 Billion | ₩1.89 Billion | ▲ +776.4% |
| 2020 | 0.17x | ₩964.40 Million | ₩5.74 Billion | ₩671.25 Million | ▲ +214.7% |
| 2019 | 0.05x | ₩156.43 Million | ₩2.93 Billion | ₩156.43 Million | ▼ -94.7% |
| 2015 | 1.01x | ₩1.43 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -43.8% |
| 2014 | 1.80x | ₩2.66 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -7.8% |
| 2012 | 1.95x | ₩17.95 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +71.3% |
| 2011 | 1.14x | ₩5.53 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -78.8% |
| 2009 | 5.36x | ₩6.62 Billion | ₩1.23 Billion | ₩6.11 Billion | — |